Our study unveiled a new mechanism by which HIF2a regulated lipid metabolism and promoted tumor progression in ccRCC; in this mechanism, HIF2a inhibits NNT expression via miR‐455‐5p to promote lipid accumulation, resulting in the progression of tumor. Here, EPAS1 is linked to nonpapillary renal cell carcinoma.